CNTGF (Centogene NV) Days Payable: 73.51 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNTGF Centogene NV CNTGF
12 GF Score
Price $0.12
View Full Analysis

What is Centogene NV Days Payable?

Centogene NV CNTGF 12 Days Payable is 73.51 as of Dec. 2023. GuruFocus rates CNTGF with a GF Score™ of 12/100.

Centogene NV's average Accounts Payable for the six months ended in Dec. 2023 was $6.83 Mil. Centogene NV's Cost of Goods Sold for the six months ended in Dec. 2023 was $16.97 Mil. Hence, Centogene NV's Days Payable for the six months ended in Dec. 2023 was 73.51.

The historical rank and industry rank for Centogene NV's Days Payable or its related term are showing as below:

CNTGF's Days Payable is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 64.48
* Ranked among companies with meaningful Days Payable only.

Centogene NV's Days Payable increased from Dec. 2022 (68.80) to Dec. 2023 (73.51). It may suggest that Centogene NV delayed paying its suppliers.

Centogene NV Days Payable Historical Data

* Premium members only.

The historical data trend for Centogene NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centogene NV Days Payable Chart

Centogene NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 99.04 204.54 288.47 120.64 68.62

Centogene NV Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.23 117.49 68.80 76.16 73.51

CNTGF vs ISPC, CHEK, FUNI: Days Payable Comparison

For the Diagnostics & Research subindustry, Centogene NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centogene NV Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's Days Payable distribution charts can be found below:

* The bar in red indicates where Centogene NV's Days Payable falls into.


CNTGF
12GF Score
Centogene NV CNTGF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centogene NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Centogene NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (6.692 + 6.137) / 2 ) / 34.119*365
=6.4145 / 34.119*365
=68.62

Centogene NV's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (7.531 + 6.137) / 2 ) / 16.967*365 / 2
=6.834 / 16.967*365 / 2
=73.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 73.51 mean?
Centogene NV (CNTGF) has a Days Payable of 73.51 as of Dec. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Centogene NV and its competitors.
Is Centogene NV's Days Payable too high?
Centogene NV's current Days Payable is 73.51. The Medical Diagnostics & Research industry median Days Payable is 64.48. Centogene NV's value of 73.51 is 14% above this industry median. Overall, Centogene NV has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Centogene NV's Days Payable compare to ISPC and CHEK?
Centogene NV's Days Payable of 73.51 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Payable is 64.48. Centogene NV's value of 73.51 is 14% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.48, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centogene NV's current Days Payable of 73.51 is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Centogene NV and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centogene NV's current Days Payable is 73.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centogene NV stock overvalued right now?
Centogene NV (CNTGF) has a current Days Payable of 73.51. The current Days Payable is 73.51 and 14% above the Medical Diagnostics & Research industry median of 64.48. Centogene NV's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Centogene NV (CNTGF), the current Days Payable is 73.51 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Centogene NV Business Description

Address Am Strande 7, Rostock, MV, DEU, 18055
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
12GF Score

Get the complete analysis for CNTGF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price